TSHA
Taysha Gene Therapies Accelerates Pivotal Development and Commercial Readiness Efforts Amid Breakthrough Therapy Designation
Taysha Gene Therapies, a pioneering biotech company, has made significant strides in the past year, solidifying its position as a leader in the gene therapy landscape. In its recently concluded full-year 2025 financial results conference call, the company provided a comprehensive update on its clinical, regulatory, and commercial readiness activities.